InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (8 ops.)
Discover the detailed record of transactions filed by Parschauer Karah Herdman, Deputy Chief Executive. Director active across 2 companies, notably Ultragenyx Pharmaceutical Inc.. In total, 12 reports have been logged. Total volume traded: €790k. The latest transaction was disclosed on 7 March 2022 — Cession. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations12 total
€297,5425,140 shares@ €57.88760.012% mcap20.3% of flow
Common Stock
SEC:0001209191-22-016931:0·
€171,4222,886 shares@ €59.39770.0070% mcap11.7% of flow
Common Stock
SEC:0001209191-22-015811:0·
015,568 shares0
Common Stock
SEC:0001570562-22-000050:0·
015,568 shares0
Common Stock
SEC:0001570562-22-000050·
€21,700310 shares@ €69.99950.0009% mcap4.4% of flow
Common Stock
SEC:0001209191-21-060752·
€21,700310 shares@ €69.99950.0009% mcap1.5% of flow
Common Stock
SEC:0001209191-21-060752:0·
€338,2767,336 shares@ €46.11180.014% mcap67.8% of flow
Common Stock
SEC:0001209191-21-055362·
€338,2767,336 shares@ €46.11180.014% mcap23.1% of flow
Common Stock
SEC:0001209191-21-055362:0·
€109,1801,329 shares@ €82.1520.0044% mcap7.4% of flow
Common Stock
SEC:0001209191-21-040108:0·
€109,1801,329 shares@ €82.1520.0044% mcap21.9% of flow
Common Stock
SEC:0001209191-21-040108·
€29,481313 shares@ €94.1870.0012% mcap5.9% of flow
Common Stock
SEC:0001209191-21-031388·
€29,481313 shares@ €94.1870.0012% mcap2.0% of flow
Common Stock
SEC:0001209191-21-031388:0·
12 of 12 declarations
About Parschauer Karah Herdman
Karah Herdman Parschauer is the Executive Vice President and General Counsel at Ultragenyx Pharmaceutical Inc. She oversees the company's legal and regulatory matters, ensuring that operations comply with applicable laws. With a strong background in the pharmaceutical sector, she plays a key role in risk management and the company's legal strategy. Her expertise is essential for navigating a complex regulatory environment.
